Skip to main content
OpenTrials
Completed

NCT Number: NCT02229409

Effectiveness of the Walking Intervention Walkadoo: A Randomized Controlled Pilot Trial in an Employee Population

This study evaluates the product Walkadoo to determine whether it effectively increases walking behavior in healthy adults.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

MeYou Health

Boston, Massachusetts, 02210, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults 18 years or older;
  • Healthways employees based in Franklin, TN with an email account with the company;
  • Provide informed consent and complete eligibility questionnaires

Exclusion criteria

  • Current or prior use of the intervention Walkadoo
  • Presence of a chronic condition that affects walking
  • Projected inability to access the internet for 4 consecutive days or longer during the study
  • Non-adherence to device wear during baseline

Treatment and study plan

Walkadoo

Behavioral

Walkadoo is a MeYou Health, LLC product.

Primary outcomes

  1. Average steps per day

    Time frame: 6 weeks

Sponsors and collaborators

Lead sponsor

MeYou Health, LLC

Industry

Registry information

Important dates

Study start
2014
Primary completion
2014
Study completion
2014
First posted
Sep 1, 2014
Registry last updated
Feb 4, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.